{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:39:23Z","timestamp":1791185963411,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"TUBITAK","award":["1085170SBAG\u20134007"],"award-info":[{"award-number":["1085170SBAG\u20134007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian Pacific Journal of Tropical Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.apjtm.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T22:15:57Z","timestamp":1505513757000},"page":"877-886","source":"Crossref","is-referenced-by-count":13,"title":["A new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan and polyacrylic acid conjugates"],"prefix":"10.4103","volume":"10","author":[{"given":"Adil M.","family":"Allahverdiyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Cakir Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melahat","family":"Bagirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Elcicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap Yesilkir","family":"Baydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Nehir","family":"Oztel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah Sefik","family":"Abamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezen Canim","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Topuzogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Isoglu Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Akdeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"10.1016\/j.apjtm.2017.09.001_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microb"},{"key":"10.1016\/j.apjtm.2017.09.001_bib2","series-title":"Control of the Leishmaniases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.apjtm.2017.09.001_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-3156.2010.02562.x","article-title":"Management of visceral leishmaniasis in rural primary health care services in Bihar, India","volume":"15","author":"Hasker","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.apjtm.2017.09.001_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr Med Chem"},{"issue":"11","key":"10.1016\/j.apjtm.2017.09.001_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1365-3156.2006.01732.x","article-title":"Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India","volume":"11","author":"Meheus","year":"2006","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.apjtm.2017.09.001_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-3156.2010.02516.x","article-title":"The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India","volume":"15","author":"Sarnoff","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.apjtm.2017.09.001_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-3156.2010.02520.x","article-title":"Household cost-of-illness of visceral leishmaniasis in Bihar, India","volume":"15","author":"Sundar","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.apjtm.2017.09.001_bib8","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J\u00a0Trop Med"},{"issue":"19","key":"10.1016\/j.apjtm.2017.09.001_bib9","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A\u00a0clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2010.08.014","article-title":"Innate immunity and leishmania vaccination strategies","volume":"29","author":"Birnbaum","year":"2011","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib11","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.apjtm.2017.09.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: a review","volume":"422","author":"Jain","year":"2015","journal-title":"J\u00a0Immunol Methods"},{"issue":"18","key":"10.1016\/j.apjtm.2017.09.001_bib13","doi-asserted-by":"crossref","first-page":"18575","DOI":"10.1074\/jbc.M400652200","article-title":"Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate","volume":"279","author":"El Fadili","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib14","first-page":"455","article-title":"Genetically modified live attenuated parasites as vaccines for leishmaniasis","volume":"123","author":"Selvapandiyan","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.apjtm.2017.09.001_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis \u2013 discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.apjtm.2017.09.001_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.2010.09-0341","article-title":"Evaluation of Ex\u00a0vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine","volume":"82","author":"Kumar","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.apjtm.2017.09.001_bib18","article-title":"Cytokine responses to novel antigens in an indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"Plos Negl Trop D"},{"issue":"46","key":"10.1016\/j.apjtm.2017.09.001_bib19","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2017.09.001_bib20","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL(R) adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.apjtm.2017.09.001_bib21","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A\u00a0clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"Nascimento","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2017.09.001_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.exppara.2009.09.017","article-title":"Leishmania major lipophosphoglycan: discrepancy in toll-like receptor signaling","volume":"124","author":"Kavoosi","year":"2010","journal-title":"Exp Parasitol"},{"issue":"14","key":"10.1016\/j.apjtm.2017.09.001_bib24","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"Pinheiro","year":"2007","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.apjtm.2017.09.001_bib25","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1073\/pnas.82.17.5910","article-title":"Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis","volume":"82","author":"Handman","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.apjtm.2017.09.001_bib26","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1073\/pnas.84.24.8941","article-title":"Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor","volume":"84","author":"Mcconville","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.140.4.1274","article-title":"Effective immunization against cutaneous leishmaniasis with defined membrane-antigens reconstituted into liposomes","volume":"140","author":"Russell","year":"1988","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.apjtm.2017.09.001_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/14760584.6.5.673","article-title":"The science of adjuvants","volume":"6","author":"Kwissa","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2008.08.001","article-title":"Dendritic cells in\u00a0vivo: a key target for a new vaccine science","volume":"29","author":"Steinman","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants \u2013 current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm J"},{"issue":"5","key":"10.1016\/j.apjtm.2017.09.001_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/eji.1830010506","article-title":"Stimulation of humoral antibody formation by polyanions. I. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells","volume":"1","author":"Diamantstein","year":"1971","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.apjtm.2017.09.001_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(90)90011-A","article-title":"Influenza vaccine \u2013 enhancement of immune-response by application of carboxy-vinylpolymer","volume":"8","author":"Oka","year":"1990","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-2427(98)00188-3","article-title":"Effect of various adjuvants on secondary immune response in chickens","volume":"66","author":"Hilgers","year":"1998","journal-title":"Vet Immunol Immunop"},{"issue":"28","key":"10.1016\/j.apjtm.2017.09.001_bib34","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/S0264-410X(00)00114-6","article-title":"Alkyl-polyacrylate esters are strong mucosal adjuvants","volume":"18","author":"Hilgers","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0939-6411(03)00093-6","article-title":"Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers","volume":"56","author":"Kusonwiriyawong","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/03079451003604647","article-title":"Safety and efficacy of an inactivated Carbopol-adjuvanted goose haemorrhagic polyomavirus vaccine for domestic geese","volume":"39","author":"Gelfi","year":"2010","journal-title":"Avian Pathol"},{"issue":"10","key":"10.1016\/j.apjtm.2017.09.001_bib37","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.4049\/jimmunol.147.10.3538","article-title":"The Leishmania-donovani lipophosphoglycan lymphocyte-t-reactive component is a tightly associated protein complex","volume":"147","author":"Jardim","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.apjtm.2017.09.001_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1423-0127-20-35","article-title":"Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis","volume":"20","author":"Topuzogullari","year":"2013","journal-title":"J\u00a0Biomed Sci"},{"issue":"6","key":"10.1016\/j.apjtm.2017.09.001_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.arcmed.2012.08.011","article-title":"Microcapillary culture method: a novel tool for in\u00a0vitro expansion of stem cells from scarce sources","volume":"43","author":"Allahverdiyev","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.apjtm.2017.09.001_bib40","first-page":"1","article-title":"Immunization with a combination of Leishmania major lipophosphoglycan (LPG) and Phlebotomus duboscqi salivary gland lysates (SGLs) abrogates protective effect of LPG against L.\u00a0major in BALB\/c mice","volume":"18","author":"Karanja","year":"2011","journal-title":"Afr J Health Sci"},{"issue":"11","key":"10.1016\/j.apjtm.2017.09.001_bib41","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.vaccine.2014.01.016","article-title":"Vaccination with Leishmania mexicana LPG induces PD-1 in CD8(+) and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy","volume":"32","author":"Salazar","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.apjtm.2017.09.001_bib42","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.72.10.5654-5661.2004","article-title":"Immunization with Leishmania major exogenous antigens protects susceptible BALB\/c mice against challenge infection with L. major","volume":"72","author":"Tonui","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.apjtm.2017.09.001_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2015.01.001","article-title":"Enhancement of siRNA lipid-based vector stability and siRNA integrity in human serum with addition of anionic polymer adjuvant","volume":"26","author":"Hamoudi","year":"2015","journal-title":"J\u00a0Drug Deliv Sci Tec"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7774\/cevr.2015.4.1.23","article-title":"Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes","volume":"4","author":"Powell","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib45","first-page":"569","article-title":"Adjuvant activity of polyelectrolytes","volume":"23","author":"Gall","year":"1972","journal-title":"Immunology"},{"key":"10.1016\/j.apjtm.2017.09.001_bib46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/polc.5070660144","article-title":"The biologic activity of polyanions: past history and new prospectives","volume":"66","author":"Regelson","year":"1979","journal-title":"J\u00a0Polym Sci Polym Symp"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib47","first-page":"363","article-title":"The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea-pigs","volume":"11","author":"Gualandi","year":"1988","journal-title":"Microbiologica"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.54846\/jshap\/453","article-title":"Effects of adjuvants on porcine circovirus type 2-associated lesions","volume":"14","author":"Hoogland","year":"2006","journal-title":"J\u00a0Swine Health Prod"},{"issue":"8","key":"10.1016\/j.apjtm.2017.09.001_bib49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/A:1020960402112","article-title":"Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants","volume":"26","author":"Tollersrud","year":"2002","journal-title":"Vet Res Commun"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/rep.1.00168","article-title":"Persistence of anti-zonae pellucidae antibodies following a single inoculation of porcine zonae pellucidae in the domestic equine","volume":"129","author":"Liu","year":"2005","journal-title":"Reproduction"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0950268800057848","article-title":"Antigenicity and immunogenicity of equine influenza vaccines containing a carbomer adjuvant","volume":"112","author":"Mumford","year":"1994","journal-title":"Epidemiol Infect"},{"issue":"13","key":"10.1016\/j.apjtm.2017.09.001_bib52","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.vaccine.2010.01.046","article-title":"Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer","volume":"28","author":"Krashias","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-3024.2010.01253.x","article-title":"Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB\/c mice","volume":"33","author":"Kaur","year":"2011","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/IAI.00611-07","article-title":"Gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with Leishmania donovani","volume":"76","author":"Bhowmick","year":"2008","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.apjtm.2017.09.001_bib55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CVI.05660-11","article-title":"Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis","volume":"19","author":"Bruhn","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4269\/ajtmh.2004.70.294","article-title":"A\u00a0sensitive new microculture method for diagnosis of cutaneous leishmaniasis","volume":"70","author":"Allahverdiyev","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.apjtm.2017.09.001_bib57","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4269\/ajtmh.2005.73.276","article-title":"The value of a new microculture method for diagnosis of visceral leishmaniasis by using bone marrow and peripheral blood","volume":"73","author":"Allahverdiyev","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4269\/ajtmh.2012.12-0034","article-title":"Utility of the microculture method in non-invasive samples obtained from an experimental murine model with asymptomatic leishmaniasis","volume":"87","author":"Allahverdiyev","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.actatropica.2013.06.009","article-title":"Utility of the microculture method for Leishmania detection in non-invasive samples obtained from a blood bank","volume":"128","author":"Ates","year":"2013","journal-title":"Acta Trop"},{"issue":"23","key":"10.1016\/j.apjtm.2017.09.001_bib60","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","article-title":"Enhanced efficacy and immunogenicity of 78 kDa antigen formulated in various adjuvants against murine visceral leishmaniasis","volume":"28","author":"Nagill","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3347\/kjp.2006.44.1.35","article-title":"Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major","volume":"44","author":"Kavoosi","year":"2006","journal-title":"Korean J Parasitol"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.exppara.2012.11.014","article-title":"Generation of avirulent Leishmania parasites and induction of nitric oxide production in macrophages by using polyacrylic acid","volume":"133","author":"Elcicek","year":"2013","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.apjtm.2017.09.001_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2014.00261","article-title":"Antigen-pulsed cpg-odn-activated dendritic cells induce host-protective immune response by regulating the t regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10","volume":"5","author":"Majumder","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib64","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.exppara.2010.12.007","article-title":"Evaluation of DNA\/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB\/c mice and its antigenic properties in human leishmaniasis","volume":"127","author":"Abdian","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.apjtm.2017.09.001_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3329\/bjmm.v3i2.5327","article-title":"Prospects of vaccine in leishmaniasis","volume":"3","author":"Salam","year":"2009","journal-title":"Bangladesh J Med Microbiol"},{"issue":"1","key":"10.1016\/j.apjtm.2017.09.001_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T\u00a0helper (h)1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.apjtm.2017.09.001_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000023900","article-title":"The Th1\/Th2 paradigm and experimental murine leishmaniasis","volume":"115","author":"Lohoff","year":"1998","journal-title":"Int Arch Allergy Imm"},{"key":"10.1016\/j.apjtm.2017.09.001_bib68","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1351\/pac200476091659","article-title":"From synthetic polyelectrolytes to polymer-subunit vaccines","volume":"76","author":"Kabanov","year":"2004","journal-title":"Pure Appl Chem"}],"container-title":["Asian Pacific Journal of Tropical Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1995764516304941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1995764516304941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:32:23Z","timestamp":1750879943000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995764516304941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1995764516304941"],"URL":"https:\/\/doi.org\/10.1016\/j.apjtm.2017.09.001","relation":{},"ISSN":["1995-7645"],"issn-type":[{"value":"1995-7645","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}